CClinicalTrials.gg
CompletedNCT00970736Updated Apr 8, 2015Results posted

Stability of Motor Output in Aging Adults

An observational study in Swallowing, sponsored by US Department of Veterans Affairs. Completed at 1 site in United States. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-04-08.

Sponsored by US Department of Veterans Affairs · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
60 Years to 80 Years
Sex
All
01

Study summary

The goal of this project is to examine the area of the brain that controls muscle movement for a group of muscles important for swallowing, and to see how that area changes over 2 weeks of time.

Read the detailed description

A large number of our nation's veterans develop dysphagia due to the myriad of potential etiological sources of swallowing disorders, including stroke and head and neck cancer. The Veteran's Health Administration has recently identified dysphagia as a major clinical focus for the VA system (Sullivan \& Dennis, 2006). In order to accurately assess adaptations in motor cortex, it is first necessary to have a reliable tool for measuring organizational representation in the motor cortex. Transcranial magnetic stimulation (TMS) is a desirable choice for such measurement because of the ability to identify causative relationships between an area of motor cortex stimulated and muscle response. Therefore, the specific research objectives of this proposal are:

  1. To demonstrate the reproducibility of TMS mapping of the submental muscle group in healthy older adults between 60 and 80 years of age
  2. To determine the neural representation of submental musculature in the motor cortex of healthy older adults between 60 and 80 years of age.

Twenty healthy adults, 10 men and 10 women, between the ages of 60 and 80 years will serve as research participants. TMS will be used to establish motor maps of the submental muscles. Subjects will undergo two testing sessions, on day 1 and day 14. The results from each session will be compared to assess excitability and representation within the motor cortex, and to assess stability and reliability of measurement.

02

Conditions studied

  • Swallowing

Keywords

  • Motor cortex
  • Motor control
  • Neuroplasticity
  • Aging
  • Swallowing
03

In context

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 658 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy adults between 60 and 80 years of age

Inclusion criteria

  • Between 60 and 80 years of age

Exclusion criteria

Exclusion Criteria:

  • History of dysphagia
  • History of neurologic disease
  • History of head or neck cancer
  • History of stroke
  • Untreated hypertension
  • History of a heart condition or heart disease
  • Currently pregnant
  • Contraindication to TMS including:

    • Metallic hardware on the scalp in the area where TMS will be applied
    • Cardiac pacemaker
    • Implanted medication pumps or an intracardiac line
    • Prior diagnosis of seizure or epilepsy in the subject (childhood history of benign febrile seizure will not be a contraindication)
    • Poorly controlled migraine headaches
    • Previous brain neurosurgery
    • Medications that can lower seizure threshold (Appendix B)
    • Unstable medical conditions
    • Lowest motor thresholds above 80% on TMS
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)

Groups and cohorts

  • 1

    20 healthy participants between 60 and 80 years of age. Ten men and 10 women.

06

What researchers measure

Primary outcomes

  1. Mean Motor Evoked Potential Amplitude for Submental Cortical Representation

    Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation. The mean sEMG amplitudes of the submental muscles for each of these sites is then calculated for the mean MEP measure.

    Time frame: 2 weeks

Secondary outcomes

  1. Motor Map Center of Gravity

    Position on the TMS motor map with highest amplitude response to stimulation in the muscles of interest (submental muscles).

    Time frame: 2 weeks

  2. Area of Submental Representation

    Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation.

    Time frame: 2 weeks

07

Results

Posted Apr 8, 2015

Participant flow

Participant flow — Overall Study
MilestoneHealthy Participants
Started20
Completed18
Not completed2

Outcome measures

PrimaryMean Motor Evoked Potential Amplitude for Submental Cortical Representation

Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation. The mean sEMG amplitudes of the submental muscles for each of these sites is then calculated for the mean MEP measure.

Time frame:
2 weeks

No measurements were reported for this outcome.

SecondaryMotor Map Center of Gravity

Position on the TMS motor map with highest amplitude response to stimulation in the muscles of interest (submental muscles).

Time frame:
2 weeks

No measurements were reported for this outcome.

SecondaryArea of Submental Representation

Cortical sites are stimulated sequentially from the SOLMT in the anterior direction. At each site, 5 pulses of 110% of the MEP threshold obtained at the SOLMT are delivered and recorded. If a site produces no MEP in 3/5 pulses it is considered non-submental. This process is continued until the entire submental representation is surrounded by non-submental responsive sites. The number of sites is used to calculate the area of submental representation.

Time frame:
2 weeks

No measurements were reported for this outcome.

Adverse events

Collected over 2 weeks (time including the day 1 testing, day 2 testing, and time in between).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Healthy Participants—0/20 (0%)—

Baseline characteristics

Healthy adults between the ages of 60 and 80 years

Age, Categorical
Age, Categorical(Participants)Healthy Participants
<=18 years0
Between 18 and 65 years4
>=65 years16
Age, Continuous
Age, Continuous(years)Healthy Participants
Mean68 ± 6
Sex: Female, Male
Sex: Female, Male(Participants)Healthy Participants
Female10
Male10
Region of Enrollment
Region of Enrollment(participants)Healthy Participants
United States20
08

Study locations

1 site
  • North Florida/South Georgia Veterans Health System
    Gainesville, Florida 32608, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00970736
Lead sponsor
US Department of Veterans Affairs
Responsible party
Sponsor
First posted
Sep 2, 2009
Start date
Nov 2009
Primary completion
Oct 2011
Completion
Oct 2011
Results posted
Apr 8, 2015
Last update
Apr 8, 2015

Study contacts

Karen Hegland, PhD
principal investigator · North Florida/South Georgia Veterans Health System

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion